A Modified Protocol for Bisulfite Genomic Sequencing of Difficult Samples
Open Access
- 24 June 2009
- journal article
- research article
- Published by Springer Nature in Biological Procedures Online
- Vol. 11 (1) , 99-112
Abstract
The bisulfite genomic sequencing protocol is a widely used method for analyzing DNA methylation. It relies on the deamination of unmethylated cytosine residues to uracil; however, its high rates of DNA degradation and incomplete cytosine to uracil conversion often lead to failed experiments, uninformative results, and false positives. Here, we report the addition of a single-step multiple restriction enzyme digestion (MRED) designed to differentially digest polymerase chain reaction products amplified from unconverted DNA while leaving those of converted DNA intact. We show that for our model system, RARB2 P2 promoter, use of MRED increased informative sequencings ninefold, and MRED did not alter the clonal representation in one fully methylated cell line, H-596, treated or not with 5-azadeoxycytidine, a methylation inhibitor. We believe that this method may easily be adapted for analyzing other genes and provide guidelines for selecting the most appropriate MRED restriction enzymes.Keywords
This publication has 44 references indexed in Scilit:
- Allelic methylation bias of the RARB2 tumor suppressor gene promoter in cancerGenes, Chromosomes and Cancer, 2008
- Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylationNucleic Acids Research, 2007
- Optimizing Annealing Temperature Overcomes Bias in Bisulfite PCR Methylation AnalysisBioTechniques, 2007
- High-Speed Conversion of Cytosine to Uracil in Bisulfite Genomic Sequencing Analysis of DNA MethylationDNA Research, 2004
- Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cellsOncogene, 2000
- Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung CarcinomasJNCI: Journal of the National Cancer Institute, 2000
- DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2ʼ-deoxycytidineAnti-Cancer Drugs, 1999
- Demethylation by 5-aza-2??-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor ?? gene in human colon carcinoma cellsAnti-Cancer Drugs, 1998
- Activation of the retinoic acid receptor ?? gene by 5-aza-2???-deoxycytidine in human DLD-1 colon carcinoma cellsAnti-Cancer Drugs, 1997
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987